Miroslav Gasparek net worth
Quick answer
Miroslav Gasparek's estimated net worth is $21.0M (range $14.7M – $31.5M) as of 2026. Miroslav Gasparek is Founder at Sensible Biotechnologies. Sensible Biotechnologies valuation.
Miroslav Gasparek is Founder at Sensible Biotechnologies (YC S21). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Education: Master's degree in Biotechnology from the Prague Institute of Chemical Technology
- Region: United Kingdom
- Industries: Healthcare, Therapeutics
- Team size: 24
- Website: https://sensible.bio
Who is Miroslav Gasparek?
Miroslav Gasparek is a founder at Sensible Biotechnologies, a Y Combinator-backed company focused on biotechnology advancements.
Highlights:
- Prague Institute of Chemical Technology
- Robert H. Smith School of Business
- Y Combinator S21
About Sensible Biotechnologies
The future of mRNA therapeutics is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible enables the next generation of mRNA medicines by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA in a scalable and cost-effective way.
FAQ: Miroslav Gasparek net worth and Sensible Biotechnologies valuation
What is Miroslav Gasparek's net worth?
Miroslav Gasparek's estimated net worth is $21.0M (range $14.7M – $31.5M) as of 2026. Miroslav Gasparek is Founder at Sensible Biotechnologies. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Sensible Biotechnologies valuation?
Sensible Biotechnologies's estimated valuation on Entrepreneurial Check is $42.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Miroslav Gasparek's role?
Miroslav Gasparek is Founder at Sensible Biotechnologies, a Y Combinator-backed startup (batch S21).